Lim M, Xia Y, Bettegowda C, Weller M. Current state of immunotherapy for glioblastoma. Nat Rev Clin Oncol. 2018;15:422–42. https://doi.org/10.1038/s41571-018-0003-5.

Article  PubMed  CAS  Google Scholar 

Cobbs C, Harkins L, Samanta M, et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 2002;62:3347–50.

PubMed  CAS  Google Scholar 

Patro ARK. Subversion of immune response by human cytomegalovirus. Front Immunol. 2019;10:1155. https://doi.org/10.3389/fimmu.2019.01155.

Article  PubMed  PubMed Central  CAS  Google Scholar 

El Baba R, Herbein G. Immune Landscape of CMV Infection in Cancer Patients: From “Canonical” Diseases Toward Virus-Elicited Oncomodulation. Front Immunol. 2021;12:730765. https://doi.org/10.3389/fimmu.2021.730765.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Coletti R, Mendonça ML, Vinga S, Lopes MB (2023) Inferring diagnostic and prognostic gene expression signatures across WHO glioma classifications: A network-based approach

Boots-Sprenger SHE, Sijben A, Rijntjes J, et al. Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with caution. Mod Pathol. 2013;26:922–9. https://doi.org/10.1038/modpathol.2012.166.

Article  PubMed  CAS  Google Scholar 

Rubiano EGO, Baldoncini M, Cómbita AL, et al. Understanding the molecular profiling of diffuse gliomas classification: a brief overview. Surg Neurol Int. 2023;14:225. https://doi.org/10.25259/SNI_209_2023.

Article  PubMed  PubMed Central  Google Scholar 

Liu Y, Zhou F, Ali H, et al. Immunotherapy for glioblastoma: current state, challenges, and future perspectives. Cell Mol Immunol. 2024;21:1354–75. https://doi.org/10.1038/s41423-024-01226-x.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tripathy DK, Panda LP, Biswal S, Barhwal K. Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches. Front Pharmacol. 2024;15:1355242. https://doi.org/10.3389/fphar.2024.1355242.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen Y, Song Y, Du W, et al. Tumor-associated macrophages: an accomplice in solid tumor progression. J Biomed Sci. 2019;26:78. https://doi.org/10.1186/s12929-019-0568-z.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ooi YC, Tran P, Ung N, et al. The role of regulatory T-cells in glioma immunology. Clin Neurol Neurosurg. 2014;119:125–32. https://doi.org/10.1016/j.clineuro.2013.12.004.

Article  PubMed  Google Scholar 

Li K, Shi H, Zhang B, et al. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Sig Transduct Target Ther. 2021;6:362. https://doi.org/10.1038/s41392-021-00670-9.

Article  Google Scholar 

Tie Y, Tang F, Wei Y, Wei X. Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets. J Hematol Oncol. 2022;15:61. https://doi.org/10.1186/s13045-022-01282-8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yuan Q, Fan Z, Huang W, et al. Human cytomegalovirus UL23 exploits PD-L1 inhibitory signaling pathway to evade T cell-mediated cytotoxicity. MBio. 2024;15:e01191-24. https://doi.org/10.1128/mbio.01191-24.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tovar-Salazar A, Weinberg A. Understanding the mechanism of action of cytomegalovirus-induced regulatory T cells. Virology. 2020;547:1–6. https://doi.org/10.1016/j.virol.2020.05.001.

Article  PubMed  CAS  Google Scholar 

Kaur B, Khwaja FW, Severson EA, et al. Hypoxia and the hypoxia-inducible-factor pathway in glioma growth andangiogenesis. Neuro-oncol. 2005;7:134–53. https://doi.org/10.1215/S1152851704001115.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Shurin MR, Umansky V. Cross-talk between HIF and PD-1/PD-L1 pathways in carcinogenesis and therapy. J Clin Invest. 2022;132:e159473. https://doi.org/10.1172/JCI159473.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Arner EN, Rathmell JC. Metabolic programming and immune suppression in the tumor microenvironment. Cancer Cell. 2023;41:421–33. https://doi.org/10.1016/j.ccell.2023.01.009.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hosseinalizadeh H, Mahmoodpour M, Samadani AA, Roudkenar MH. The immunosuppressive role of indoleamine 2, 3-dioxygenase in glioblastoma: mechanism of action and immunotherapeutic strategies. Med Oncol. 2022;39:130. https://doi.org/10.1007/s12032-022-01724-w.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lin H, Liu C, Hu A, et al. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives. J Hematol Oncol. 2024;17:31. https://doi.org/10.1186/s13045-024-01544-7.

Article  PubMed  PubMed Central  Google Scholar 

Himes BT, Geiger PA, Ayasoufi K, et al. Immunosuppression in glioblastoma: current understanding and therapeutic implications. Front Oncol. 2021;11:770561. https://doi.org/10.3389/fonc.2021.770561.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sumaiya K, Langford D, Natarajaseenivasan K, Shanmughapriya S. Macrophage migration inhibitory factor (MIF): a multifaceted cytokine regulated by genetic and physiological strategies. Pharmacol Ther. 2022;233:108024. https://doi.org/10.1016/j.pharmthera.2021.108024.

Article  PubMed  CAS  Google Scholar 

Lamano JB, Lamano JB, Li YD, et al. Glioblastoma-derived IL6 induces immunosuppressive peripheral myeloid cell PD-L1 and promotes tumor growth. Clin Cancer Res. 2019;25:3643–57. https://doi.org/10.1158/1078-0432.CCR-18-2402.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cobbs C. Cytomegalovirus is a tumor-associated virus: armed and dangerous. Curr Opin Virol. 2019;39:49–59. https://doi.org/10.1016/j.coviro.2019.08.003.

Article  PubMed  Google Scholar 

Herbein G. High-risk oncogenic human cytomegalovirus. Viruses. 2022;14:2462. https://doi.org/10.3390/v14112462.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Herbein G. The human cytomegalovirus, from oncomodulation to oncogenesis. Viruses. 2018;10:408. https://doi.org/10.3390/v10080408.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cobbs CS, Soroceanu L, Denham S, et al. Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1–mediated mitogenicity. Cancer Res. 2008;68:724–30. https://doi.org/10.1158/0008-5472.CAN-07-2291.

Article  PubMed  CAS  Google Scholar 

Lucas KG, Bao L, Bruggeman R, et al. The detection of CMV pp65 and IE1 in glioblastoma multiforme. J Neurooncol. 2011;103:231–8. https://doi.org/10.1007/s11060-010-0383-6.

Article  PubMed  CAS  Google Scholar 

Rahbar A, Orrego A, Peredo I, et al. Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival.